The weekly litigation news digest is live. Subscribe now

IP Verse

Antineoplastic Combinations Of Neratinib And Capecitabine - EP3175853

The patent EP3175853 was granted to Wyeth on Nov 1, 2023. The application was filed on Aug 4, 2009 under application number EP16203986A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3175853

WYETH
Application Number
EP16203986A
Filing Date
Aug 4, 2009
Status
Granted And Under Opposition
Sep 29, 2023
Publication Date
Nov 1, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
SANDOZJul 2, 2024ELKINGTON AND FIFEADMISSIBLE

Patent Citations (30) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2005059678
DESCRIPTIONUS2007104721
DESCRIPTIONUS4966891
DESCRIPTIONUS5453497
DESCRIPTIONUS5472949
DESCRIPTIONUS5476932
DESCRIPTIONUS6002008
DESCRIPTIONUS6288082
DESCRIPTIONUS6297258
DESCRIPTIONUS6780996
DESCRIPTIONUS7297795
DESCRIPTIONUS7399
DESCRIPTIONUS865
DESCRIPTIONWO9633978
DESCRIPTIONWO9633980
EXAMINATIONWO2010017163
OPPOSITIONWO2005018677
OPPOSITIONWO2006081985
OPPOSITIONWO2006113151
OPPOSITIONWO2006120557
OPPOSITIONWO2007056118
OPPOSITIONWO2008076143
OPPOSITIONWO2009042613
SEARCHWO2005018677
SEARCHWO2006081985
SEARCHWO2006113151
SEARCHWO2006120557
SEARCHWO2007056118
SEARCHWO2008076143
SEARCHWO2009042613

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents